Notice of Intent to Sole Source for Recombinant WR I1, A10 and MBP-D8 proteins

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to ARVYS Proteins Inc for Recombinant WR I1, A10 and MBP-D8 proteins. Arvys has provided several recombinant proteins for our program that have been incorporated into our assays. These proteins are unique to ARVYS and are needed for expanded testing in mpox species specific assay developmentThis contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within four (4) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to William Brannen at [email protected] by 10:00 A.M. EST., September 11, 2023